enGene Holdings Inc. ( ENGN) - Stock Earnings
ENGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Sept. 14, 2026, midnight | — / — | — | — / — | — |
ENGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -37.9 million USD | — USD |
| 2025Q4 | -29.8 million USD | — USD |
| 2026Q1 | 30.2 million USD | — USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
ENGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -99.9 million USD | — USD |
| 2024 | -55.1 million USD | — USD |
| 2025 | -117.3 million USD | — USD |
| 2026 Est. | — | — |
ENGN
Price: $1.78
52 week price:
Dividend Yield: 38.89%
Earnings Per Share: -2.18 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 92.2 million